Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-04-18Apabetalone for Pulmonary Arterial Hypertension: a Phase 2 Clinical Study
-
CLINICAL_TRIALS study record update · 2023-03-14StratosPHere: Optimal Biomarkers to Ascertain Target Engagement in Therapies Targeting the BMPR2 Pathway in Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2023-03-06A Phase 2, Randomized, Double-BLInd, Placebo- Controlled Study of UBEnimex in Patients With Pulmonary ARTerial HYpertension (WHO Group 1) (LIBERTY)
-
CLINICAL_TRIALS study record update · 2023-02-27A Phase 2, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Safety, Tolerability and Efficacy of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo as Add-On Therapy in Symptomatic Subjects With Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2023-02-21Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Withdrawal Study of Pulmonary Arterial Hypertension(PAH) Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric Oxide (INO)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-02-21An Open-Label Long-Term Safety Study of Inhaled Nitric Oxide (iNO) for PAH for Subjects in the PULSE-PAH-006 and PULSE-PAH-004 Studies Who Continue to Need iNO Therapy
-
CLINICAL_TRIALS study record update · 2023-02-10A Phase 2a Single-Arm, Open-Label, Multicenter Exploratory Study to Assess the Effects of Sotatercept (ACE-011) for the Treatment of Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2023-02-01Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain
-
CLINICAL_TRIALS study record update · 2023-01-27Sleep Disordered Breathing in Precapillary Pulmonary Hypertension: Effect of CPAP Treatment
-
CLINICAL_TRIALS study record update · 2023-01-25A Phase 3, Placebo Controlled, Double-Blind, Randomized, Clinical Study to Determine Efficacy, Safety, and Tolerability of Pulsed, Inhaled Nitric Oxide (iNO) Versus Placebo in Symptomatic Subjects With PAH (Part 1 and Part 2)
-
CLINICAL_TRIALS study record update · 2023-01-18A Phase 2, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
-
CLINICAL_TRIALS study record update · 2022-12-21Effects of a Home Telerehabilitation Program Via Videoconference in Patients With Pulmonary Arterial Hypertension- Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-12-20Feasibility Study to Determine if Novel Wearable Monitoring System and Machine-Learning Algorithm Can Model Continuous Pulmonary Artery Pressure Recordings in Human Subjects
-
CLINICAL_TRIALS study record update · 2022-12-07A Randomised, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Inhaled Doses of Imatinib Inhalation Solution (AER-901) in Adult Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2022-11-21Study to Determine if Novel Wearable Monitoring System and Machine-Learning Algorithm Can Model Continuous Pulmonary Artery Pressure Recordings in Human Subjects
-
CLINICAL_TRIALS study record update · 2022-11-16The Combined Use of Radiofrequency-catheter-ablation and Balloon-atrial-septostomy (CURB) in the Creation of a Stable Inter-atrial Communication:a Preliminary Study in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2022-11-07Real World Andalusian Multicenter Data on Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists
-
CLINICAL_TRIALS study record update · 2022-10-27Angiotensin Converting Enzyme (ACE2), Brain, Gut Dysbiosis in Pulmonary Hypertension
-
CLINICAL_TRIALS study record update · 2022-10-20The Consistency of Cardiac Output Measured by Electrical Cardiometry and Pulmonary Artery Catheter in Cardiac Surgery Patients With Pulmonary Arterial Hypertension or Right Heart Dysfunction
-
CLINICAL_TRIALS study record update · 2022-10-18Biomarkers in Congenital Heart Diseases and Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2022-10-06Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With Right Heart Failure Caused by Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2022-10-03Revatio Special Investigation - Investigation for Long-Term Use of Revatio in Pediatric Patients
-
CLINICAL_TRIALS study record update · 2022-09-28Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension: a Multicenter, Randomized, Double-blind, Placebo-controlled Study
-
CLINICAL_TRIALS study record update · 2022-09-19Long-term Single-arm Open-label Study, to Assess the Safety and Tolerability of ACT-293987 in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2022-08-23A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)